THURSDAY, May 27, 2021 (HealthDay News) — An experimental antibody therapy may help ease skin symptoms from the autoimmune disease lupus, a small preliminary trial suggests. Researchers found that a higher-dose version of the drug spurred a “clinically meaningful” symptom improvement for 87% of patients after one month. But theyContinue Reading

THURSDAY, May 27, 2021 (HealthDay News) — A third antibody treatment designed to keep high-risk COVID-19 patients from winding up in the hospital was approved for emergency use by the U.S. Food and Drug Administration on Wednesday. Importantly, in lab tests the newly authorized drug, dubbed sotrovimab, neutralized the highlyContinue Reading

COVID-19 Vaccines May Give Protection for Years: Studies COVID-19 vaccines may provide protection for at least a year, and possibly even a lifetime to people who were previously exposed to the virus, two new studies suggest. Both of them looked at people who had been exposed to the coronavirus (SARS-CoV-2)Continue Reading

THURSDAY, May 27, 2021 (HealthDay News) — Patients facing relatively simple outpatient surgeries are nonetheless being told to undergo a number of preoperative tests that just aren’t necessary, a new study reports. More than half of a group of patients facing low-risk outpatient surgery received one or more tests —Continue Reading

THURSDAY, May 27, 2021 (HealthDay News) — The U.S. government and nonprofits are replacing drug companies as the main drivers of Alzheimer’s disease research, two new studies show. The findings are from an analysis of national data by Jeffrey Cummings, a research professor at the University of Nevada, Las VegasContinue Reading